Sylvia M. Lee

1.9k total citations
19 papers, 1.3k citations indexed

About

Sylvia M. Lee is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Sylvia M. Lee has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Immunology and 3 papers in Surgery. Recurrent topics in Sylvia M. Lee's work include CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Sylvia M. Lee is often cited by papers focused on CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Sylvia M. Lee collaborates with scholars based in United States, South Africa and Austria. Sylvia M. Lee's co-authors include A. McGarry Houghton, Julia Kargl, Martin McIntosh, Stanley R. Riddell, Grace Yang, Kim Margolin, Heather Metz, Kyoung-Hee Kim, Jesse J. Hubbard and Stephanie Busch and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Sylvia M. Lee

18 papers receiving 1.3k citations

Peers

Sylvia M. Lee
Paúl E. Clavijo United States
Jie Qing Chen United States
Michelle R. Padget United States
Josephine R. Giles United States
Xin Tang China
Iva Truxová Czechia
Carlos de Andrea Spain
Andrew J. Gunderson United States
Kerstin Wennhold Germany
Akihiro Hosoi Japan
Paúl E. Clavijo United States
Sylvia M. Lee
Citations per year, relative to Sylvia M. Lee Sylvia M. Lee (= 1×) peers Paúl E. Clavijo

Countries citing papers authored by Sylvia M. Lee

Since Specialization
Citations

This map shows the geographic impact of Sylvia M. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia M. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia M. Lee more than expected).

Fields of papers citing papers by Sylvia M. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia M. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia M. Lee. The network helps show where Sylvia M. Lee may publish in the future.

Co-authorship network of co-authors of Sylvia M. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia M. Lee. A scholar is included among the top collaborators of Sylvia M. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia M. Lee. Sylvia M. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Parvathaneni, Upendra, George E. Laramore, Neil Panjwani, et al.. (2025). Adjuvant Proton Beam Radiation Therapy for Sinonasal Mucosal Melanoma. Cancer Reports. 8(2). e70111–e70111. 1 indexed citations
2.
3.
Sillah, Arthur, Ulrike Peters, Nathaniel F. Watson, et al.. (2022). Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot study. Supportive Care in Cancer. 30(5). 3829–3838. 1 indexed citations
4.
Qureshi, Hannan A., Xiaodong Zhu, Grace Yang, et al.. (2022). Impact of HPV status on immune responses in head and neck squamous cell carcinoma. Oral Oncology. 127. 105774–105774. 14 indexed citations
5.
Sillah, Arthur, Scott S. Tykodi, Evan Hall, et al.. (2021). Predictive Lifestyle Markers for Efficacy of Cancer Immune Checkpoint Inhibitors: A Commentary. Future Oncology. 17(4). 363–369. 1 indexed citations
6.
Srivastava, Shivani, Scott N. Furlan, Carla A. Jaeger-Ruckstuhl, et al.. (2020). Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade. Cancer Cell. 39(2). 193–208.e10. 232 indexed citations
7.
Rodriguez, Cristina P., Qian Wu, Jenna Voutsinas, et al.. (2019). A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer. Clinical Cancer Research. 26(4). 837–845. 135 indexed citations
8.
Veatch, Joshua, Julia Kargl, Matthew Fitzgibbon, et al.. (2019). Endogenous CD4+ T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 ( Her2 ) Driver Mutations. Cancer Immunology Research. 7(6). 910–922. 70 indexed citations
9.
Qureshi, Hannan A. & Sylvia M. Lee. (2019). Immunotherapy Approaches Beyond PD-1 Inhibition: the Future of Cellular Therapy for Head and Neck Squamous Cell Carcinoma. Current Treatment Options in Oncology. 20(4). 31–31. 8 indexed citations
10.
Margolin, Kim, Chihiro Morishima, Vamsidhar Velcheti, et al.. (2018). Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 24(22). 5552–5561. 146 indexed citations
11.
Veatch, Joshua, Sylvia M. Lee, Matthew Fitzgibbon, et al.. (2018). Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma. Journal of Clinical Investigation. 128(4). 1563–1568. 91 indexed citations
12.
Kargl, Julia, Stephanie Busch, Grace Yang, et al.. (2017). Neutrophils dominate the immune cell composition in non-small cell lung cancer. Nature Communications. 8(1). 14381–14381. 290 indexed citations
13.
Chapuis, Aude G., Sylvia M. Lee, John A. Thompson, et al.. (2016). Combined IL-21–primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient. The Journal of Experimental Medicine. 213(7). 1133–1139. 68 indexed citations
14.
Chapuis, Aude G., Ilana M. Roberts, John A. Thompson, et al.. (2016). T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression. Journal of Clinical Oncology. 34(31). 3787–3795. 85 indexed citations
15.
Bhatia, Shailender, Scott S. Tykodi, Sylvia M. Lee, & John A. Thompson. (2015). Systemic therapy of metastatic melanoma: on the road to cure.. PubMed. 29(2). 126–35. 24 indexed citations
16.
Pollack, Seth M., Robin L. Jones, Erik Farrar, et al.. (2014). Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8+ T cells. Journal for ImmunoTherapy of Cancer. 2(1). 36–36. 42 indexed citations
17.
Lee, Sylvia M., James Moon, Bruce G. Redman, et al.. (2014). Phase 2 study of RO4929097, a gamma‐secretase inhibitor, in metastatic melanoma: SWOG 0933. Cancer. 121(3). 432–440. 81 indexed citations
18.
Lee, Sylvia M. & Laura Q.M. Chow. (2014). A new addition to the PD-1 checkpoint inhibitors for non-small cell lung cancer-the anti-PDL1 antibody-MEDI4736.. PubMed. 3(6). 408–10. 18 indexed citations
19.
Chapuis, Aude G., John A. Thompson, Kim Margolin, et al.. (2012). Abstract LB-136: IL-21-derived melanoma-reactive CTL combined with anti-CTLA4 persist, acquire central memory characteristics, and mediate tumor regression in patients with metastatic melanoma. Cancer Research. 72(8_Supplement). LB–136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paúl E. Clavijo Breakdown of academic impact, for papers by Jie Qing Chen Breakdown of academic impact, for papers by Michelle R. Padget Breakdown of academic impact, for papers by Josephine R. Giles Breakdown of academic impact, for papers by Xin Tang Breakdown of academic impact, for papers by Iva Truxová Breakdown of academic impact, for papers by Carlos de Andrea Breakdown of academic impact, for papers by Andrew J. Gunderson Breakdown of academic impact, for papers by Kerstin Wennhold Breakdown of academic impact, for papers by Akihiro Hosoi
Rankless by CCL
2026